A story of microalbuminuria and diabetic nephropathy - PubMed (original) (raw)

Review

A story of microalbuminuria and diabetic nephropathy

Bijan Roshan et al. J Nephropathol. 2013 Oct.

Abstract

Context: It is estimated that more than 346 million people worldwide have diabetes mellitus . By the year 2030, it is predicted that diabetes will become the seventh leading cause of death in the world. Development of chronic kidney disease (CKD) in patients with diabetes adds significantly to the morbidity and mortality and significantly increases health care costs, even before the development of end stage renal disease (ESRD). Evidence acquisitions: Directory of Open Access Journals (DOAJ), Google Scholar, Pubmed (NLM), LISTA (EBSCO) and Web of Science have been searched.

Results: Diabetic nephropathy (DN) is increasing rapidly worldwide. It is the leading cause of new cases of ESRD in the USA. Interestingly, although DN is the most common cause of ESRD in diabetic patients, diabetes mellitus is also an independent and strong risk factor for ESRD ascribed to causes other than DN (e.g. hypertensive nephropathy).

Conclusions: It is important to be aware of the pitfalls of using the urine albumin level in predicting development and progression of diabetic nephropathy in order to treat and advise the patients accurately. Research into finding new markers is rapidly evolving but current progress makes it likely we will be using the urine albumin level for some years into the future.

Keywords: Chronic kidney disease; Diabetic nephropathy; Microalbuminuria.

PubMed Disclaimer

Figures

Figure 1.Pathologic stages of DM nephropathy (adopted with permission from J Am Soc Nephrol. 2010.Apr;21(4):556-63.

Figure 1.Pathologic stages of DM nephropathy (adopted with permission from J Am Soc Nephrol. 2010.Apr;21(4):556-63.

References

    1. WHO Fact sheet N°312 August 2011; WHO Media Centre.
    1. Laliberté F, Bookhart BK, Vekeman F, Corral M, Duh MS, Bailey RA, Piech CT, Lefebvre P. Direct All-Cause Health Care Costs Associated With Chronic Kidney Disease in Patients With Diabetes and Hypertension: A Managed Care Perspective. J Manag Care Pharm. 2009 ;15(4):312–22. - PMC - PubMed
    1. Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. JAMA. 1997;278:2069–2074. - PubMed
    1. Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, Ferrario F, Fogo AB, Haas M, de Heer E, Joh K, Noël LH, Radhakrishnan J, Seshan SV, Bajema IM, Bruijn JA. Renal Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556–63. - PubMed
    1. Wison JL, Root HF, Marble A. Diabetic nephropathy; a clinical syndrome. N Engl J Med. 1951;245(14):513–7. - PubMed

Publication types

LinkOut - more resources